Effectiveness of microcurrent therapy and botulinum therapy in patients with erythematous-telangiectatic subtype of rosacea

The article presents current data on etiology and pathogenesis rosacea, listed endogenous and exogenous provoking factors. The pathogenetic justification given of the use of botulinum toxin type A in erythematosus-teleangiectatic subtype rosacea. A study involving 32 patients with ETP was carried out, during which a combination treatment was used – a course of microcurrent therapy followed by botulinum therapy by mesotechnics (in two different breedings). According to the results of the study, a pronounced clinical effect was established in patients. The results were evaluated using an analog VAS scale as well as DIQL. We came to conclusions about the effectiveness of combined use of microcurrent therapy and botulinum therapy in erythematosus-teleangiectatic subtype rosacea and the feasibility of further study of this issue.